Your browser is no longer supported. Please, upgrade your browser.
Settings
VRTX [NASD]
Vertex Pharmaceuticals Incorporated
IndexS&P 500 P/E21.29 EPS (ttm)10.30 Insider Own0.20% Shs Outstand258.43M Perf Week2.83%
Market Cap57.23B Forward P/E16.75 EPS next Y13.10 Insider Trans-12.77% Shs Float258.30M Perf Month1.06%
Income2.71B PEG1.16 EPS next Q2.72 Inst Own94.80% Short Float1.64% Perf Quarter-2.98%
Sales6.21B P/S9.22 EPS this Y128.00% Inst Trans-1.48% Short Ratio2.05 Perf Half Y-19.18%
Book/sh33.61 P/B6.53 EPS next Y15.90% ROA25.70% Target Price285.42 Perf Year-17.14%
Cash/sh25.53 P/C8.59 EPS next 5Y18.33% ROE35.20% 52W Range202.57 - 306.08 Perf YTD-7.17%
Dividend- P/FCF19.12 EPS past 5Y45.30% ROI26.40% 52W High-28.15% Beta0.68
Dividend %- Quick Ratio4.20 Sales past 5Y43.20% Gross Margin88.10% 52W Low8.56% ATR4.62
Employees3400 Current Ratio4.30 Sales Q/Q15.20% Oper. Margin46.00% RSI (14)57.51 Volatility1.80% 2.09%
OptionableYes Debt/Eq0.07 EPS Q/Q3.90% Profit Margin43.70% Rel Volume0.44 Prev Close219.39
ShortableYes LT Debt/Eq0.06 EarningsFeb 01 AMC Payout0.00% Avg Volume2.07M Price219.90
Recom1.80 SMA202.31% SMA502.76% SMA200-8.58% Volume742,675 Change0.23%
Feb-23-21Upgrade Robert W. Baird Neutral → Outperform $220 → $252
Feb-02-21Reiterated H.C. Wainwright Buy $315 → $275
Dec-30-20Initiated Daiwa Securities Outperform $250
Nov-30-20Upgrade RBC Capital Mkts Sector Perform → Outperform $247 → $267
Nov-20-20Initiated Bernstein Outperform $225
Oct-28-20Initiated UBS Buy $287
Jul-31-20Reiterated H.C. Wainwright Buy $295 → $315
Jul-08-20Downgrade Morgan Stanley Overweight → Equal-Weight $300
Apr-30-20Reiterated H.C. Wainwright Buy $270 → $295
Apr-28-20Downgrade RBC Capital Mkts Outperform → Sector Perform $250 → $260
Mar-04-20Initiated Barclays Overweight $271
Jan-31-20Downgrade Robert W. Baird Outperform → Neutral $210 → $230
Nov-19-19Upgrade Guggenheim Neutral → Buy $252
Nov-12-19Initiated SunTrust Buy $235
Oct-17-19Resumed BofA/Merrill Buy $220
Sep-03-19Upgrade Goldman Neutral → Buy $226 → $254
Aug-01-19Downgrade Needham Buy → Hold
May-23-19Resumed Citigroup Buy $205
May-21-19Initiated Credit Suisse Outperform $209
Apr-12-19Initiated Evercore ISI In-line
Apr-19-21 09:01AM  
Apr-18-21 06:06AM  
Apr-17-21 09:01AM  
07:00AM  
Apr-16-21 09:12AM  
06:04AM  
Apr-14-21 05:50PM  
Apr-13-21 05:50AM  
Apr-11-21 09:03AM  
Apr-08-21 04:20PM  
Apr-07-21 06:01AM  
Apr-05-21 05:51AM  
Apr-02-21 08:06AM  
Mar-31-21 01:33PM  
Mar-28-21 06:01AM  
Mar-26-21 07:23AM  
Mar-24-21 07:21PM  
05:50PM  
08:19AM  
Mar-23-21 02:38PM  
10:12AM  
Mar-22-21 06:04AM  
Mar-20-21 06:30AM  
06:04AM  
Mar-17-21 11:48AM  
Mar-16-21 12:19PM  
08:24AM  
Mar-14-21 06:18AM  
05:51AM  
Mar-11-21 05:45PM  
08:52AM  
Mar-10-21 01:04PM  
07:55AM  
Mar-09-21 10:25AM  
06:06AM  
Mar-07-21 07:19AM  
06:06AM  
Mar-05-21 07:00AM  
Mar-03-21 11:30AM  
Mar-02-21 05:51AM  
Feb-24-21 09:01AM  
Feb-21-21 06:36AM  
Feb-20-21 07:10AM  
Feb-19-21 07:50AM  
Feb-18-21 12:49PM  
Feb-17-21 02:00PM  
08:19AM  
Feb-15-21 06:22AM  
Feb-14-21 05:51AM  
Feb-11-21 08:53AM  
Feb-06-21 05:36PM  
Feb-05-21 09:32AM  
07:55AM  
Feb-03-21 10:25AM  
06:10AM  
Feb-02-21 04:35PM  
10:26AM  
10:25AM  
06:03AM  
Feb-01-21 10:30PM  
05:56PM  
05:25PM  
04:53PM  
04:39PM  
04:01PM  
02:30PM  
06:06AM  
05:43AM  
Jan-31-21 03:58AM  
Jan-30-21 01:19PM  
Jan-29-21 10:12AM  
09:39AM  
09:31AM  
08:44AM  
08:22AM  
07:45AM  
06:12AM  
Jan-28-21 04:11PM  
08:42AM  
Jan-27-21 11:13AM  
11:05AM  
Jan-26-21 09:40AM  
08:30AM  
Jan-25-21 05:45PM  
03:45PM  
12:30PM  
06:01AM  
Jan-24-21 07:10AM  
Jan-22-21 09:01AM  
05:51AM  
Jan-21-21 12:10PM  
Jan-20-21 08:23AM  
Jan-19-21 10:46AM  
Jan-18-21 08:03AM  
Jan-15-21 05:45PM  
Jan-11-21 08:02AM  
Jan-10-21 07:05AM  
06:06AM  
Jan-08-21 05:45PM  
Jan-07-21 09:01AM  
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial; VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial; and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; Molecular Templates, Inc.; and Affinia Therapeutics. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanna BastianoEVP, Cell & Genetic TherapiesApr 05Sale214.141,686361,04635,834Apr 07 04:04 PM
Liu JoySVP, General CounselMar 05Sale209.695,1411,078,0188,253Mar 08 04:10 PM
Silva Paul MSVP & Chief Accounting OfficerMar 01Sale211.452,782588,2559,884Mar 02 04:07 PM
Silva Paul MSVP & Chief Accounting OfficerFeb 25Sale213.471,080230,55114,884Feb 26 04:23 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 25Sale213.423,586765,30740,133Feb 26 04:20 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 25Sale213.383,028646,12530,837Feb 26 04:18 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 25Sale213.543,634775,98941,103Feb 26 04:07 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 25Sale213.393,028646,13933,589Feb 26 04:03 PM
Silva Paul MSVP & Chief Accounting OfficerFeb 18Sale211.834,295909,82816,828Feb 19 04:21 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 18Sale211.839,2641,962,36646,665Feb 19 04:20 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 18Sale211.837,8251,657,55636,281Feb 19 04:18 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 18Sale211.827,8251,657,48147,635Feb 19 04:08 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 18Sale211.837,8251,657,59039,033Feb 19 04:05 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 11Sale210.554,460939,06863,542Feb 16 04:20 PM
Silva Paul MSVP & Chief Accounting OfficerFeb 11Sale210.571,498315,43723,863Feb 16 04:24 PM
Sanna BastianoEVP, Cell & Genetic TherapiesFeb 11Sale210.561,686355,01238,864Feb 16 04:22 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 11Sale210.564,318909,17950,346Feb 16 04:15 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 11Sale210.555,1561,085,59361,700Feb 16 04:07 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 11Sale210.545,2831,112,27453,098Feb 16 04:02 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 05Option Exercise86.521,930166,98459,157Feb 09 07:44 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 05Sale215.001,930414,95057,227Feb 09 07:44 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 03Option Exercise86.521,554134,45271,511Feb 05 04:43 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 03Option Exercise86.5240034,60857,627Feb 05 04:52 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 03Sale213.741,554332,14669,957Feb 05 04:43 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 03Sale216.5640086,62457,227Feb 05 04:52 PM
Sachdev AmitEVP, Chief Patient OfficerNov 16Sale223.53429,38835,103Nov 18 04:16 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffNov 16Sale223.539120,34126,838Nov 18 04:12 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerNov 16Sale223.6471,56535,179Nov 18 04:11 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 16Sale223.47388,49228,902Nov 18 04:10 PM
SACHS BRUCE IDirectorNov 10Buy217.3615,0003,260,46526,210Nov 12 08:18 AM
Parini MichaelEVP, Chief Adm, Leg & BD OffNov 04Option Exercise86.522,330201,59229,168Nov 06 04:09 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffNov 04Sale217.742,330507,32926,838Nov 06 04:09 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerNov 03Option Exercise86.521,553134,36636,732Nov 05 04:16 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerNov 03Sale211.921,553329,11535,179Nov 05 04:16 PM
Bhatia Sangeeta N.DirectorOct 05Option Exercise126.688,7291,105,79014,424Oct 07 04:11 PM
Bhatia Sangeeta N.DirectorOct 05Sale266.7910,5162,805,5183,908Oct 07 04:11 PM
Silva Paul MSVP & ControllerAug 06Option Exercise169.391,078182,59816,010Aug 10 04:24 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 06Option Exercise155.571,223190,26230,125Aug 10 04:13 PM
Kewalramani ReshmaCEO & PresidentAug 06Option Exercise179.682,073372,48228,699Aug 10 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 06Option Exercise155.571,223190,26228,061Aug 10 04:22 PM
Silva Paul MSVP & ControllerAug 06Sale271.171,078292,31914,932Aug 10 04:24 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 06Sale271.191,223331,66328,902Aug 10 04:13 PM
Kewalramani ReshmaCEO & PresidentAug 06Sale271.202,073562,20526,626Aug 10 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 06Sale271.201,223331,67226,838Aug 10 04:22 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 03Option Exercise86.522,330201,59231,232Aug 05 04:14 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerAug 03Option Exercise86.521,553134,36636,732Aug 05 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 03Option Exercise86.522,330201,59229,168Aug 05 04:20 PM
Silva Paul MSVP & ControllerAug 03Option Exercise86.5280969,99515,741Aug 05 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerAug 03Option Exercise86.521,941167,93537,044Aug 05 04:51 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 03Sale278.242,330648,29028,902Aug 05 04:14 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerAug 03Sale278.391,553432,33735,179Aug 05 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 03Sale278.282,330648,40226,838Aug 05 04:20 PM
Silva Paul MSVP & ControllerAug 03Sale278.30809225,14214,932Aug 05 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerAug 03Sale278.281,941540,13735,103Aug 05 04:51 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffJul 13Option Exercise90.292,125191,86628,963Jul 15 04:41 PM
Silva Paul MSVP & ControllerJul 13Option Exercise90.2986077,64915,792Jul 15 04:51 PM
Silva Paul MSVP & ControllerJul 13Sale292.03860251,14514,932Jul 15 04:51 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffJul 13Sale292.052,125620,61026,838Jul 15 04:41 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJul 10Sale293.15700205,20616,126Jul 14 04:16 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJul 07Option Exercise173.512,786483,40337,965Jul 09 04:13 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJul 07Sale300.002,786835,80035,179Jul 09 04:13 PM
LEIDEN JEFFREY MExecutive ChairmanJun 30Sale286.1532,7929,383,3042,261Jul 02 04:15 PM
Bhatia Sangeeta N.DirectorJun 02Sale282.88952269,2985,695Jun 03 04:22 PM
Kewalramani ReshmaCEO & PresidentMay 15Sale284.179928,13226,626May 19 04:35 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 15Sale284.0012034,08012,738May 19 04:33 PM
Silva Paul MSVP & ControllerMay 15Sale284.0015142,88514,932May 19 04:31 PM
Sachdev AmitEVP, Chief Patient OfficerMay 15Sale284.415816,49635,103May 19 04:29 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 15Sale284.406819,33926,838May 19 04:28 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerMay 15Sale283.9811332,08935,179May 19 04:22 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 15Sale284.378223,31828,902May 19 04:21 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 12Option Exercise187.531,304244,53930,206May 14 04:17 PM
LEIDEN JEFFREY MExecutive ChairmanMay 12Option Exercise137.5288,53212,174,639129,353May 14 04:19 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 12Sale287.331,304374,67828,902May 14 04:17 PM
LEIDEN JEFFREY MExecutive ChairmanMay 12Sale283.4794,37026,751,44034,983May 14 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 11Option Exercise187.531,304244,53928,142May 13 04:18 PM
Sachdev AmitEVP, Chief Patient OfficerMay 11Option Exercise131.8910,6651,406,60745,768May 13 04:20 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 11Sale286.001,304372,94426,838May 13 04:18 PM
Sachdev AmitEVP, Chief Patient OfficerMay 11Sale282.6110,6653,014,01435,103May 13 04:20 PM
LEIDEN JEFFREY MExecutive ChairmanMay 07Option Exercise137.5288,53412,174,982135,190May 08 04:20 PM
SACHS BRUCE IDirectorMay 07Option Exercise70.5545,0003,174,52556,210May 08 04:24 PM
SACHS BRUCE IDirectorMay 07Sale269.8045,00012,140,80611,210May 08 04:24 PM
LEIDEN JEFFREY MExecutive ChairmanMay 07Sale269.7894,36925,459,01340,821May 08 04:20 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 06Option Exercise155.571,222190,10730,124May 08 04:17 PM
Kewalramani ReshmaCEO & PresidentMay 06Option Exercise179.672,074372,63828,700May 08 04:19 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 06Option Exercise174.06966168,14613,704May 08 04:28 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 06Option Exercise155.571,222190,10728,060May 08 04:22 PM
Sachdev AmitEVP, Chief Patient OfficerMay 06Option Exercise131.8966988,23435,772May 08 04:23 PM
Silva Paul MSVP & ControllerMay 06Option Exercise169.381,076182,25516,008May 08 04:26 PM
Silva Paul MSVP & ControllerMay 06Sale272.741,076293,47214,932May 08 04:26 PM
Sachdev AmitEVP, Chief Patient OfficerMay 06Sale275.28669184,16235,103May 08 04:23 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 06Sale272.641,222333,16526,838May 08 04:22 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 06Sale272.70966263,43112,738May 08 04:28 PM
Kewalramani ReshmaCEO & PresidentMay 06Sale272.852,074565,88226,626May 08 04:19 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 06Sale272.661,222333,19528,902May 08 04:17 PM
Sachdev AmitEVP, Chief Patient OfficerMay 05Option Exercise131.8913,3561,761,52348,459May 06 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05Option Exercise137.5288,53712,175,273141,028May 07 04:24 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05Sale269.9494,37225,475,03746,656May 07 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerMay 05Sale270.0113,3563,606,23235,103May 06 04:43 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 04Option Exercise86.522,330201,59229,168May 06 04:25 PM
Silva Paul MSVP & ControllerMay 04Option Exercise86.5280969,99515,741May 06 04:27 PM